Supplementary Figure 5 from High BCR–ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib
التفاصيل البيبلوغرافية
العنوان:
Supplementary Figure 5 from High BCR–ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib
American Association for Cancer Research (AACR), 2023.
سنة النشر:
2023
الوصف:
Figure 5. Nomograms predicting eight-year FFS probabilities according to BCR-ABL/GUSIS expression at diagnosis and the Sokal (panel A) or Hasford (panel B) prognostic scores were generated by stratifying patients for these variables and then using a modified Cox proportional hazard model. Differences observed between the various patient subgroups were statistically significant (p
